Literature DB >> 12045722

Natural history of multiple sclerosis: implications for counselling and therapy.

Christian Confavreux1, Sandra Vukusic.   

Abstract

Recent advances in our knowledge of the natural history of multiple sclerosis deal with the influence of pregnancy and vaccination, the predictive value of magnetic resonance imaging-based criteria in terms of activity and severity of the disease, and the weighting of the interplay between relapses and clinical progression. These advances have implications for counselling of patients and adjusting the classification of the disease course. Thus multiple sclerosis should be considered to be as much neurodegenerative as inflammatory and disease-modifying therapeutic strategies should be reconsidered by focusing on protection and repair of the nervous system.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12045722     DOI: 10.1097/00019052-200206000-00006

Source DB:  PubMed          Journal:  Curr Opin Neurol        ISSN: 1350-7540            Impact factor:   5.710


  9 in total

Review 1.  Thermoregulation in multiple sclerosis.

Authors:  Scott L Davis; Thad E Wilson; Andrea T White; Elliot M Frohman
Journal:  J Appl Physiol (1985)       Date:  2010-07-29

2.  Is size an essential criterion to define tumefactive plaque? MR features and clinical correlation in multiple sclerosis.

Authors:  Lucia Patriarca; Silvia Torlone; Fabiana Ferrari; Caterina Di Carmine; Rocco Totaro; Ernesto di Cesare; Alessandra Splendiani
Journal:  Neuroradiol J       Date:  2016-08-16

3.  Cerebral tumefactive demyelinating lesions.

Authors:  Wei Qi; G E Jia; Xinsheng Wang; Maozhi Zhang; Zhenyu Ma
Journal:  Oncol Lett       Date:  2015-07-10       Impact factor: 2.967

4.  Reproducibility of three whole-brain N-acetylaspartate decline cohorts in relapsing-remitting multiple sclerosis.

Authors:  O Gonen; T A Oberndorfer; M Inglese; J S Babb; J Herbert; R I Grossman
Journal:  AJNR Am J Neuroradiol       Date:  2007-02       Impact factor: 3.825

5.  Multiple sclerosis and pregnancy: what does the patient think? a questionnaire study.

Authors:  Peter Albrecht; Dorothea Fischer; Andreas Moser
Journal:  BMC Res Notes       Date:  2010-04-03

6.  Zinc-ion binding and cytokine activity regulation pathways predicts outcome in relapsing-remitting multiple sclerosis.

Authors:  A Achiron; M Gurevich; Y Snir; E Segal; M Mandel
Journal:  Clin Exp Immunol       Date:  2007-05-04       Impact factor: 4.330

7.  High-dose immunosuppressive therapy and autologous peripheral blood stem cell transplantation for severe multiple sclerosis.

Authors:  Richard A Nash; James D Bowen; Peter A McSweeney; Steven Z Pavletic; Kenneth R Maravilla; Man-soo Park; Jan Storek; Keith M Sullivan; Jinan Al-Omaishi; John R Corboy; John DiPersio; George E Georges; Theodore A Gooley; Leona A Holmberg; C Fred LeMaistre; Kate Ryan; Harry Openshaw; Julie Sunderhaus; Rainer Storb; Joseph Zunt; George H Kraft
Journal:  Blood       Date:  2003-05-22       Impact factor: 22.113

8.  Clinical and radiographic spectrum of pathologically confirmed tumefactive multiple sclerosis.

Authors:  C F Lucchinetti; R H Gavrilova; I Metz; J E Parisi; B W Scheithauer; S Weigand; K Thomsen; J Mandrekar; A Altintas; B J Erickson; F König; C Giannini; H Lassmann; L Linbo; S J Pittock; W Brück
Journal:  Brain       Date:  2008-06-05       Impact factor: 13.501

Review 9.  New immunopathologic insights into multiple sclerosis.

Authors:  Bernhard Hemmer; Bernd Kieseier; Sabine Cepok; Hans-Peter Hartung
Journal:  Curr Neurol Neurosci Rep       Date:  2003-05       Impact factor: 5.081

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.